Literature DB >> 14218460

EFFECT OF CLOFIBRATE AND ANDROSTERONE ON HYPERCHOLESTEROLAEMIC XANTHOMATOSIS.

B MASON, C B PERRY.   

Abstract

Entities:  

Keywords:  ANDROSTERONE; BUTYRATES; HYPERCHOLESTEREMIA; PHARMACOLOGY; XANTHOMATOSIS

Mesh:

Substances:

Year:  1965        PMID: 14218460      PMCID: PMC2165081          DOI: 10.1136/bmj.1.5427.102

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  3 in total

1.  THE TREATMENT OF HYPERCHOLESTEROLAEMIC XANTHOMATOSIS WITH ATROMID.

Authors:  E M JEPSON; D C JAMES
Journal:  J Atheroscler Res       Date:  1963 Sep-Dec

2.  Reduction of serum-lipid and uric-acid levels by an orally active androsterone.

Authors:  M F OLIVER
Journal:  Lancet       Date:  1962-06-23       Impact factor: 79.321

3.  EFFECTS OF ETHYL CHLOROPHENOXYISOBUTYRATE, ALONE OR WITH ANDROSTERONE (ATROMID) ON SERUM LIPIDS, LIPOPROTEINS AND RELATED METABOLIC PARAMETERS IN NORMAL AND HYPERLIPIDEMIC SUBJECTS.

Authors:  R P HOWARD; P ALAUPOVIC; O J BRUSCO; R H FURMAN
Journal:  J Atheroscler Res       Date:  1963 Sep-Dec
  3 in total
  1 in total

1.  Clofibrate in lipoid dermato-arthritis.

Authors:  D N Golding
Journal:  Br Med J       Date:  1966-09-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.